
Journal of Heterocyclic Chemistry p. 1307 - 1311 (1996)
Update date:2022-09-26
Topics:
Boyer
Fournel
Nicolai
Teulon
A new synthetic route to prepare the 2-hydroxy-5-methyl-7-n-propyl-8-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]m ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine (UP 269-6, Ripisartan) is described. UP 269-6 is a non-peptide angiotensin II antagonist currently in phase
View MoreShanghai Yuanye Bio-Technology Co., Ltd.
website:http://www.shyuanye.com
Contact:+86-21-61845781
Address:Building 6, No. 465, Changta Road,Songjiang District,Shanghai,China
Contact:0510-85393305
Address:1619 Huishan Avenue, Huishan District, Wuxi,
Suzhou Sibian Chemical Technology Co., Ltd
website:http://www.sibianpharm.com
Contact:+8618169181984,+8618013186906
Address:Room1404,BuildingA,Jiabao Square No.323 Baodai East Road,Wuzhong District,Suzhou Jiangsu China (215128)
Nanjing Fubang Chemical Co.,Ltd
Contact:+86-25-83179199
Address:5F,Tianzheng international plaza,No399 Zhongyang Road ,Nanjing China
SJZ Chenghui Chemical Co., Ltd.
Contact:86-311-87713916
Address:no.368 youyi north avenue
Doi:10.1021/jo01234a004
(1936)Doi:10.1021/ol403096g
(2013)Doi:10.1246/cl.1993.705
(1993)Doi:10.1039/c004547k
(2010)Doi:10.1002/hlca.19930760207
(1993)Doi:10.1021/jm981005y
(1998)